Oncothyreon HomeContactSite MapGlossary
Oncothyreon
Small Molecules
PX-866

Development Status

We currently expect to file an IND for PX-866 in the first quarter of 2008 and begin a Phase 1 trial in the second quarter of 2008.

 

          © 2008 Oncothyreon.
 

About Oncothyreon | Pipeline | Clinical Trials | Business Development | Investors | News & Events